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ABSTRACT
Family medicine has come of age, with family 
doctors/general practitioners taking on greater roles and 
responsibilities and health care systems recognizing the 
important role of primary care. It is in this scenario that 
the question of pre- and post- testing counselling of 
genetic tests which are or would be offered directly to the 
general public through advertising and over-the-counter 
testing is being raised. This type of counselling would 
require enough personnel to deal with a large number 
of people; people who may not have genetic disorders 
in their families but who are curious about testing 
such as that for Breast Cancer (BRCA). It is argued that 
family doctors, albeit needing continuing professional 
development in this area, already have a solid foundation 
in genetics and are strategically placed in the community 
and numerous enough to impart such counselling. This 
would also liberate the responsibility from specialised 
geneticists who need to deal with families and individuals 
who have more serious genetic disorders to be managed.
Key Words: General practitioners, family doctors / 
physicians, strategically placed, community, genetic 
counselling, family medicine.  
INTRODUCTION
For more than a decade the debate on who should 
impart pre- and post- test counselling for genetic tests 
has been discussed. To many, it seems that family doctors 
(also known as family physicians or general practitioners) 
are the key to this solution as they are numerous enough, 
are strategically placed in the community, and easily 
available to the general public who may have questions 
regarding what they hear and see about such testing. 
It is important in this regard to consider that 
specialized geneticists cannot be disturbed from the 
secondary care job they do and should not be dragged 
into a primary care scenario. They are usually clinic / 




Should family physicians counsel patients  
on genetic testing and screening?
close to the same families in the midst of communities 
as family doctors are. Moreover, although updates 
and training in the type of counselling (as opposed to 
normal psychological counselling) is necessary, doctors 
have a clear understanding from the nature of their jobs 
of the underlying science of genetics. Their Colleges 
and Associations carry a responsibility to impart this 
continuing professional development for the good of 
society. It is argued as well that family medicine has 
‘come of age’ and that it is no longer the Cinderella of 
medicine – family doctors are considered specialists 
and registered as such after having had formal training 
post-medical school. 
What is special about genetic tests –  
the real concerns
Genetic information has a tremendous potential 
to harm as well as to help and stands to affect a broad 
number of family members (McCanse, 2001). Even well-
educated patients may be ill-prepared to understand or 
deal realistically with the results of genetic tests. The 
primary care culture is different from the genetics culture 
but primary care doctors are more community-oriented, 
asking what specific aspects of a genetic approach to this 
health problem (or potential problem) are likely to benefit 
this patient. Howard Brody warns family doctors about 
the perils of genetic testing for patients and the role the 
family physician must play (McCanse, 2001, p.1). The 
ability to genetically screen for diseases far outpaces 
the ability to treat conditions, such as breast cancer, 
Alzheimer’s disease and prostate cancer. Nonetheless 
people often consider genetic tests as some sort of cure 
or prevention of the condition (Lapp, 2002).
Companies may use advertising to entice people into 
believing that they should have genetic tests carried out 
(Chandros Hull & Prasad, 2001). They sometimes advise 
potential patients that there is no need to consult the 
family doctor or anybody else as their own ‘experts’ will 
guide the patients into what tests they should carry out. 
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However genetic tests may not only affect individuals 
adversely, but also their family members. In this context 
it is fair for family physicians and their societies and 
colleges to be wary of the effect these tests can have 
over patients and their family members. Conversely 
family doctors, without the proper Continuing Medical 
Education (CME) imparted specifically to meet the needs 
of ongoing ethical dilemmas in genetic tests, may find 
themselves ordering such tests too liberally, once it is the 
patient who requests them, believing they are respecting 
the individual’s autonomy. Family physicians have been 
‘urged to warn’ patients of the potential pitfalls and 
dangers of using over-the-counter testing as prices start 
to fall. Whilst tests may sound enticing to patients, the 
impact they can have on their personal lives may not be 
divulged fairly and squarely by someone trying to market 
the test (Tanday, 2012).
Whilst the definition of genetic counselling continues 
to evolve, Ciarleglio et al. (2003) argue that the 
identification of susceptibility genes for common adult 
genetic diseases is moving the field of counselling into 
newer more challenging times. Genetic counsellors 
are also faced with having to translate more and more 
information which emerge from genetic tests into a way 
which can aid clients to make decisions, and which will 
reduce stress and anxiety, to enhance the ability to make 
life choices (Bennett et al. 2003). Weber and Corban 
(1996) note that although today geneticists perform 
most testing and counselling for genetic disorders, in the 
near future family physicians will increasingly become 
responsible for this role. Whilst the reasons for testing 
may be simple, they are likely to ignite fierce issues 
regarding cost, ethics, insurability, patient expectations 
and information which family members may wish not 
to know. How should family doctors consider the role 
in regard to genetic testing and counselling? In the light 
of this New Genetics, it may be envisaged that people 
will first inundate primary care physicians for answers 
to their questions. GPs accept they have an increasing 
role to play but may still show some lack of confidence 
in this area. Emery et al. (1999) say that the experience 
with counselling on cystic fibrosis in the UK is strong 
evidence to support the importance of providing genetic 
services in the primary care setting.   Moreover the 
Association of American Family Physicians states in an 
editorial of its journal that several studies found that 
patients would prefer their family physician to facilitate an 
informed decision-making process on genetic testing and 
to counsel them about preventive measures. Although 
family physicians may feel yet quite unprepared due to 
what the editors call the ‘big bang’ in the knowledge of 
genetics, they strongly believe in the ‘larger role in genetic 
counselling’ that family physicians should take (Martin 
& Wilikofsky, 2012)
What are the concerns of genetic tests?
Why should genetic tests cause concern to family 
doctors more than any other form of test? The prime 
reason is indeed the novelty of these tests and the aura 
they are raising. Awareness campaigns sponsored by 
companies need to be considered for what they may 
actually be – an impetus for them to promote their 
product. While such a campaign need not to be bad in 
itself, if it is to be endorsed by the medical profession, 
the latter has the responsibility towards society not to 
be an accomplice in enticing patients to spend more 
than they should on such tests. Definitely not everyone 
needs do genetic tests and therefore fears must be 
quelled. Who is in a better position to quell such fears 
than family physicians who enjoy the trust of patients 
and their families? Some may argue that once these tests 
are available it is not the onus of any physician to try to 
convince someone not to do them. If one considers a 
commercially-available breast cancer (BRCA) test without 
any proper counselling however, there will be those who 
may not be aware of implications such tests carry to 
their employment, insurance and family when balanced 
against what management is available should they test 
positive - such as a radical mastectomy. This has enticed 
many states in the USA to have laws protecting against 
inappropriate access of such tests to the public. But in 
other countries such laws do not yet exist.
Studies on bilateral prophylactic oophorectomy vs. 
radical mastectomy (Kauff & et al, 2002; Rebbeck & 
et al., 2002) show that this is a highly evolving field in 
which it is wise to seek the advice of a doctor. Haber, 
analysing the relevance in the statics of such results, 
showed only that more studies are necessary. Thus 
by no means is there any certainty about outcomes of 
BRCA testing other than to recommend it to women 
past childbearing age and counselling them about an 
oophorectomy should they test positive (Haber, 2002). 
Again the operation does not exempt them completely 
from breast cancer. Notwithstanding the effectiveness 
of bilateral prophylactic radical mastectomy as has been 
demonstrated (Meijers et al., 2001), the controversy over 
such radical treatment remains.
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Point-of-care Genetic Counselling;  
the role of the Family Physician
Whereas it is undisputed that the General Practitioner 
is in an ideal position to counsel patients on genetic 
testing (BMA, 1998. p. 120) and to know where to 
refer patients for specialized counselling, Brody argues 
that a balance has to be stuck between the physicians’ 
hunches, the patient’s wishes and the evidence of clinical 
trials (Lapp, 2002). As mentioned, one concern which 
is not being addressed adequately, for example, is the 
implications such tests pose for family members. A 
possible solution he proposes is that the family doctor 
is in a position to set up a ‘family covenant’ before an 
individual goes through with testing. Such a document 
would be negotiated among the family members with 
the help of the physician. Family members who ‘opt in’ 
for set conditions are privy to the knowledge that comes 
out (Lapp, 2002). Yet the concept of covenant is lagging 
behind advances in genetic testing and it is doubtful how 
much such a covenant is possible before family doctors 
establish themselves as the agents of basic counselling.
The British Medical Association (BMA) document 
argues that primary care physicians should be able to 
identify patients and families who would need further 
genetic counselling by specialists, arguing that the 
rapidity with which genetic technology is developing and 
the complexity of the decisions to be made in relation 
to genetic testing mean that specialized pre- and post-
test genetic counselling are likely to be required (BMA, 
1998. p121). This however only refers to identification of 
individuals and families who need specialist counselling. 
It is unlikely that genetic counsellors can reach the 
public as much as the family physicians because of their 
smaller numbers and their less easy accessibility for the 
more general genetic tests being advertised. Moreover 
the family doctor already knows much about the family 
and probably its requirements and would be able to 
identify who would benefit from genetic information. 
The family doctor is familiar with the background and 
family dynamics in a way that a specialized counsellor can 
never be: it is information obtained over time within the 
context of practicing family medicine. Indeed if it were 
possible for the counsellor to arrive to such knowledge, 
it could be argued that this would be a repetition and 
waste of time for health professionals and patients alike.
Boxes 1 and 2 (BMA, 1998. p. 123-124) show 
respectively the process of genetic counselling and the 
framework of exploring decisions laid down by both the 
BMA and the American Society for Human Genetics. 
Nothing in this list is in fact beyond the capabilities of the 
average primary care physician. If people seek the advice 
of the family physician, it is appropriate that the latter 
should be able to handle most questions and counselling, 
leaving to the specialist those who have serious genetic 
inheritance problems. For those patients seeking to know 
more about cancer genes, paternity testing and even 
genetic screening of the unborn, the family physician is 
in an ideal and maybe better position to impart advice. 
Family physicians are moreover prescriptive by nature 
and thus tend to be more directive than the average non-
directive genetic counsellor (Ibid. p122).
There are then additional reasons why general genetic 
counselling should be imparted by family doctors. The 
strategically placed primary point-of-care position of the 
family physician favours the role that genetic counselling 
should play in primary care physician. If people seek 
the advice of thefamily physician, it is appropriate that 
the latter should beable to handle most questions and 
counselling, leaving tothe specialist those who have 
serious genetic inheritanceproblems. For those patients 
seeking to know moreabout cancer genes, paternity 
testing and even geneticscreening of the unborn, the 
family physician is in anideal and maybe better position 
to impart advice. Familyphysicians are moreover 
prescriptive by nature and thustend to be more directive 
than the average non-directivegenetic counsellor (BMA, 
1998.p122).
Of course the family doctor can never replace the role 
of the specialized genetic counsellor just as he can never 
replace the specialized radiographer and cardiologist. 
But the energy of the specialist counsellor is better 
spent on the hard core cases like Huntington’s and Tay 
Sachs, rather than where the industry is striking hard, 
namely the cancer genes and such tests as ‘cardiovascular 
panels’ and ‘thrombosis panels’ which are aimed to raise 
awareness of the public but which may also satisfy a profit 
motive trumping over a benevolent principle. Specialized 
counsellors can then continue doing what they have been 
doing up till now – provide specialised services.
Conversely, if one considers countries where newly-
formed companies offer genetic testing to the public, 
where family physicians provide no such counselling, 
such fertile ground is the ideal incubator for releasing 
‘awareness information’ onto the public catching doctors 
off guard. Before there is enough time to prepare for 
genetic counselling services, people will start believing 
that there is some inherent cure in carrying out such tests 
(Lapp, 2002). On the other hand, doctors unaware of 
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the implications of such tests will not counsel the public 
properly, as has been the subtle warning of the BMA. 
Specialized services, even if they do exist in theory in 
the main general hospitals, will not be enough to handle 
the everyday questions about genetic tests and definitely 
cannot direct patients into what tests are necessary. An 
appointment with the service may run into months just to 
handle the cases that truly need specialized counselling.
This highlights the importance of recognising that 
general practitioners are strategically placed to train 
themselves in imparting this counselling, which being 
a core medical subject is already in their realm. It is the 
responsibility of colleges, association and academics of 
family physicians to counsel members to learn more 
about genetic counselling. There will be no grass-root 
availability to answer questions about genetic tests of 
which one has heard about over the media.
The coming of age of Family Practice
A second important reason is the coming of age of 
family practice. Whilst the history of medicine shows 
that the family doctor or community doctor was the 
traditional doctor (Porter, 1996) (p.118)), the last century 
saw a surge of specialists and sub-specialists. In Britain 
the Royal College of General Practitioners was founded 
after the war and incorporated within it almost all general 
practitioners. It became the strongest political body in 
Britain to bargain with government over the structure of 
the National Health Service (Porter, 1996). Conversely, 
in the United States, the American Academy of Family 
Physicians brought together Family Doctors raising the 
status of Family Medicine to that of a speciality. Similar 
roads were taken in other countries. Family Medicine is 
now recognised and listed as a Speciality in its own right 
in the European Union and other continents are adopting 
vocational training in the field.
Family doctors now provide more and more services 
which can be offered to people at more reasonable rates 
making it more acceptable to insurance companies. 
GPs have always traditionally carried out minor surgery 
such as removal of sebaceous cysts, cautery of warts and 
injection of internal haemorrhoids. Nowadays more and 
more GPs take on more engaging non-invasive surgery 
such as removal of lipomas, injection of varicose veins, 
circumcisions and even haemorroidectomies (Brown, 
1992) Studies (Siepel et al., 2000) have shown that 
family doctors who attend a course in ultrasonography 
can perform ultrasounds as part of an annual physical 
examination, detecting pathology such as renal tumours, 
aortic aneurysms and others, before any signs and 
symptoms are present. Family doctors in the United 
States train in sigmoidoscopy, gastroscopy, colposcopy 
and can even have a whole radiological set-up if 
economically viable. All of this is in the interest of quick 
diagnostics bypassing long referral lists and delays in a 
secondary care setting. The UK has been at the forefront 
experimenting with ‘pathways’ aimed at reducing costs 
and waiting times for the NHS and patients respectively, 
with the GP playing the key role in these reductions. In 
this setting it is reasonable to assume that family doctors 
with continued medical education (CME) are taking 
onto themselves more and more diagnostic techniques 
which not only increase the scope of general practice but 
which result in more benefit to patients. With proper 
CME a genetic counselling service to people and their 
families is clearly within the scope and definition of 
family practice. 
What is needed with the impact of genetic 
technologies therefore is a primary care setting that can 
explain tests to all people, not only to those who have 
some genetic disorder in their lineage. Someone with 
a family history of colon cancer may inquire about the 
relevance and validity of genetic tests; it is reasonable to 
assume also that any woman may request information 
about whether she should have a BRCA test done. 
She may not know she needs counselling (in terms 
of implications for herself and her relatives and for 
insurance and employment interests). Therefore besides 
providing strategic community point-of-care contact, 
family physicians can bring a broader scope to genetic 
counselling. They are trained to think of issues such 
as getting patients to get their houses insured before 
getting tests done (Lavallee, 1999).
Consequently it is unreasonable to assume or 
request genetic counsellors to have to deal with this sort 
of mass population counselling. They would lose time 
which is valuable to what they are doing at present - 
counselling families, which may indeed be identified by 
family doctors, in need of further in-depth evaluation. 
Unless genetic counsellors increase in numbers and 
become almost as common as the family doctor they 
may not be able to handle the amount of information 
which necessarily would need to be imparted to 
keep up with the media and the rapidly expanding 
genetic industry. Starfield et al. (2002, p.51) argue that if 
genetic problems including initiating diagnosis and even 
management, should be considered, primary-care centred 
systems offer the greatest resource for improving health.
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Training – certification /  
re-validation and vocational training
Studies do show that one cannot take for granted 
that since someone is a doctor, no formal professional 
development in this regard is necessary. In the first 
instance the counselling to be imparted is not the type 
of counselling we usually associate with psychologists, 
or, for that matter the counselling GPs can usually give to 
patients with psychological or family problems (Patient 
UK, 2012). It is conversely an integral part of the genetic 
testing process to involve both pre-test and post-test 
counselling. Whilst a genetic test may be available, a 
family physician would typically ask why the patient is 
asking about such a test at that point in time; what does 
the patient seek and what do they intend to do with the 
results? Making an analysis of whether they are ready can 
guide family physicians in taking appropriate care about 
consequences at first-contact point-of-care.
Guidance will certainly include explaining the impact 
any result will have on relatives and the fact that laws 
may oblige one to disclose information to other family 
physicians who are responsible for their relatives (Fulda 
& Lykens, 2006) and any decisions and legislation 
taken in this regard at a national level. Where no such 
legislation and guidelines exist, family physicians can act 
as patient advocates cautioning against over-the-counter 
genetic testing, for example. 
In a study in New Zealand, Morgan et al (2012) 
found that General Practitioners have an increasingly 
important role to play in genetics but that the best 
way to implement future educational strategies need 
to be well considered. In their study, most GPs felt 
that they lacked experience and knowledge of genetic 
testing and had received very little formal training, even 
though they recognized the important role they have 
in this area. As highlighted earlier, Geller et al. (2012) 
confirmed that family physicians may be more directive 
in their counselling from conclusions of a study which 
included obstetricians, pediatricians, internists, family 
practitioners, and psychiatrists; this involved counselling 
patients on prenatal diagnosis and abortion. Certainly 
the change in attitude they advocate for primary care 
physicians would also have to include viewing genetic 
counselling from a much broader perspective than merely 
limiting it to reproductive issues.
The main areas of genetic clinical testing are antenatal 
screening and cancer genetics testing. More is promised 
in the future. However, the British Journal of General 
Practice has recently said that in providing genetic 
counselling, a family history may still be the most 
important tool so far, and that it is often neglected as part 
of a diagnosis (Walter & Emery, 2012). The editorial says 
that data from people who have taken over-the-counter 
genetic testing have not really had an impact on their 
change in life-styles.  Perhaps this is a further argument 
why the pre- and post-genetic counselling should in 
fact be done by the family doctor, who stands in clinical 
equipoise (as opposed to someone trying to sell the test) 
with regard to the person considering the reason they 
want testing. Perhaps curiosity without a motivation to 
BOX 1 (BMA, 1998)
“The British Medical Association states that genetic counseling consists of a series of activities which make a coherent whole. For 
ease of analysis we separate them in the list given below. In reality, however they are not separate entities, but facets of one process. 
In general terms, genetic counseling includes:
•	 Taking a family history and establishing a diagnosis;
•	 Gaining an understanding of the social and cultural context within which a patient and his or her family live and the values 
they bring to the counseling process;
•	 Listening to the questions and anxieties of the patient;
•	 Providing information about the condition, its inheritance pattern, and its management and raising questions about the 
potential significance of sharing information with other family members;
•	 Giving information about reproductive options; and/or 
•	 Giving information about predictive options (if applicable);
•	 Providing the opportunity to reflect upon the options (implications counseling);
•	 Providing emotional support; and
•	 Initiating sustained help, if necessary, to enable individuals to adjust to particular life circumstances (psycho-therapeutic 
counseling).”
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change life style may make the patient reconsider testing 
unless there are more important reasons to do so, such 
as new forms of treatment. O’Brian says that there is no 
evidence that information obtained from genetic tests 
‘will be as valuable as the marketing suggests’ (O’Brian, 
2012). Moreover, family physician Nancy Stevens 
stresses the importance of injecting the family practice 
perspective into genetic medicine (McCanse, 2001). As 
this perspective is still underrepresented in conversations 
of genetic medicine, it means that patients of family 
practitioners are underrepresented. For example, she 
points out that only someone from high-risk families 
tends to benefit from BRCA testing.
The role and responsibility of associations 
and colleges
Certainly the responsibility taken on by family 
physicians is greater and respective colleges and 
associations may need to undertake the training of their 
members both in what we mean by counselling; what 
counselling should be done by family physicians, and 
of course when they should refer. Once it is accepted 
that the family doctor has this role to play in imparting 
knowledge and genetic counselling to patients, 
associations and colleges have an obligatory role to 
see that its members get the CME required in genetic 
counselling. Family doctors, by their very nature, are 
already in a position to give evidence-based information, 
genetics being one speciality they have always had in 
their curriculum. It would be unreasonable not to accept 
their role in providing such evidence-based counselling.
Associations and colleges of family doctors, which 
strive to guarantee excellence of their members to the 
public, have a special role to play here. But primary-care 
centred systems may pose a risk of underdetection and 
undermanagement of genetic problems if information 
BOX 2 (BMA, 1998)
The description of genetic counseling set out by the American Society of Human Genetics is as follows:
Genetic counseling is a communication process which deals with the human problems associated with the occurrence or risk 
of occurrence, of a genetic disorder in a family. This process involves an attempt by one or more appropriately trained persons to 
help the individual or family:
(1) comprehend the medical facts, including the diagnosis, the probable course of the disorder and the available management;
(2) appreciate the way heredity contributes to the disorder, and the risk of recurrence in specified relatives;
(3) understand the options for dealing with the risk of recurrence;
(4) choose the course of action which seems appropriate to them in view of their risk and their family goals and act in 
accordance with the decision;
(5) make the best possible adjustment to the disorder in an affected member and/or to the risk of recurrence of that disorder.
and other educational networks do not actively support 
practitioners (Starfield et al. 2002, p. 51). Whereas it may 
be obvious that a family doctor intending to carry out 
diagnostic ultrasonography would require training, it may 
not be that obvious that to do genetic counselling one 
also needs training, because genetics has always formed 
part of the medical undergraduate curriculum. The focus 
of counselling is not on Mendelian inheritance explained 
in layman terms, but is a matter of explaining the social, 
legal and ethical implications of these tests and also of 
having a clear understanding of why they are so different 
than merely having a blood count done. Doctors need 
to understand and explain that genetic tests are largely 
non-therapeutic and predictive. The patient therefore 
needs to be empowered with information by someone 
who realizes the full potential of these tests and how 
industry may exploit fear of disease without concern for 
other family members and implications on employment 
and insurability.
Associations must guarantee that their members will 
explain the harm/benefit of genetic testing and screening. 
They must also guarantee that they will continue to seek 
the interests of the family and not only of individual 
people seeking testing. In other words, family doctors 
need to maintain the trust of the public, that financial 
gain is not the main motive of the counselling as may be 
the case for the company providing that test. 
CONCLUSION
Whilst more recently a qualitative study published in 
the British Journal of General Practice has raised concerns 
about British GPs welcoming an enhanced role in clinical 
genetics and that the effectiveness on education policy 
aimed solely on knowledge is questionable (Mathers 
et al., 2010), it should be acknowledged that generally 
patients will go to their family doctors for enquiry because 
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they are strategically placed and available. In any case, in 
many instances they would need a referral by their doctor 
for genetic services. The family doctor will already have 
considerable ‘genetic’ knowledge through the patient’s 
family history (Mathers et al., 2010) and should be 
in a position not only to act as gatekeeper, given that 
genetic counsellors are limited, but to recognize his/her 
role in prevention and intervention – to avoid direct-to-
consumer advertisement and over-the-counter analysis, 
and to counsel patients through the information they 
would need to know both before and after a test and 
indeed empower patients to make an informed choice.
